Marina Levochkina, MPH 🦠🧠

MS3 @VTCSOM
@PittPubHealth Infectious Diseases Alum
I model (statistically)
Interested in Anesthesia & CCM

[Marina Levochkina, MPH 🦠🧠 @marinantherocks]

Our publication is out!
Neutrophil-to-Lymphocyte Ratios🩸 and Infections🦠 After Traumatic Brain Injury🧠: Associations with Hospital Resource Utilization and Long-Term Outcome🏥 1/
https://t.co/97sT3mRu1F

[IMCrit @IM_Crit_]

Cardiogenic shock reminder - A management approach:

[Ed Livingston @ehlJAMA]

DO GLP-1 Agonists Really Cause Eye Disease

There has been a huge amount of press about a report showing an association between the use of GLP-1 agonists and Nonarteritic anterior ischemic optic neuropathy (NAION)

https://t.co/IjBl0wN10a

Because of it being heavily promoted by JAMA, the article has an Altmetric score of 1982. However, despite wide dissemination of the study's conclusions, very few people actually read the article (only 3,918 downloads-consider the denominator here: 1 million physicians in the US and 10 million healthcare providers).

The conclusions should not be accepted without critical analysis of the study itself. There are limitations:

1) This disease occurs in patients with diabetes. GLP-1 drugs are generally used for more advanced cases of DM. There was no control for diabetes severity in the study. It is likely that the NAION was more likely to occur in patients with more severe DM - the same population more likely to be prescribed GLP-1 agonists. The lack of control for DM severity is a major limitation and probably should negate any conclusion about the relationship between GLP-1 agonists and eye disease.

Note form the limitations section: "our study also is
limited in that the severity of confounding factors could not be adequately assessed,"

At a minimum, this analysis should have controlled for HgA1c levels.

2) The study had an extremely small number of patients and the population was not representative of the average patient with DM. Of 979 eligible patients, only 32 had NAION. Of these 27 were treated with semaglutide and 5 with other drugs. Semaglutide is not a 1rst line treatment for DM. That the majority of patients in this study were being treated with this drug suggests that the patients had severe, probably poorly controlled DM. Note #1 above- the statistical analysis for this study did not include control for DM severity.

See: DM Standards of Care from the ADA: https://t.co/hFlR9wPj25
The first line treatment for DM is diet control, weight loss and metformin. GLP-1 agonist drugs are advised when these fails or if treating patients with a high risk for DM complications.

2) From the methods: Propensity matching was used to assess whether prescribed semaglutide was associated with NAION in patients with type 2 diabetes (T2D) or overweight/obesity. Propensity methods do not balance unmeasured risk variables or confounders. They also result in loss of information and power by excluding patients who cannot be matched. In the study, there were 32 patients with a NAION event. Of these only 23 were studied after a propensity score match and 18 after propensity score and exact matching. How the excluded patients might affect the results is unknown.

3) As mentioned in a previous tweet (X?), the confidence intervals for the study results were huge. This happens when there are too few events to reliably analyze.

From the abstract:

"A Cox proportional hazards regression model showed higher risk of NAION for patients receiving semaglutide (hazard ratio [HR], 4.28; 95%CI, 1.62-11.29); P < .001)."

"A Cox proportional hazards regression model showed a higher risk of NAION for patients prescribed semaglutide (HR, 7.64; 95%CI, 2.21-26.36; P < .001)."

As a general rule, findings with very large confidence intervals should be considered suspect-In other words, there is not a lot of confidence in the results.

The figure got a lot of attention. Note that the effect was magnified by an insert showing survival probabilities between 90 and 100. the figure looks dramatic because of this. this got the public's attention but is misleading. There are no confidence intervals in this graph to show how well separated the groups survival really was. Given the very small numbers of patients, the CIs probably showed significant overlap.

The major problem here is that this research really does not show an association between NAION and GLP-1 drugs-Yet, it was widely summarized by the press and made its rounds through social media. It came to my attention when someone sent e the article suggesting that our group look at this problem in more detail.

It would be nice if there was more critical review of findings like these before the public absorbed the conclusions.

I am sure there is more to this article than I picked up on and look forward to more discussion about it.

Social media is probably a better venue for peer review for scientific findings than journals-This comes from someone who was a JAMA editor for many years. SM enables broader audience to draw upon for comment and facilitates expression of a diversity of views.

[Mara Bahri, MD @MaraBahri]

Kevin Lee, an MS4 @OhioStateMed + newly matched into Neurology was diagnosed with a rare brain cancer in March of 2024.

Since his diagnosis, he’s had a brain biopsy, multiple LPs, and just finished his first round of chemotherapy.

[Shematologist, MD @acweyand]

This article is as beautiful as it is heart wrenching.

Written by ⁦@MottChildren⁩ PICU physician Dr Erica Andrist. https://t.co/WwirAYSLHh

[Josh McGough, MD @joshmcgoo]

Alert and oriented to person place and vibe

[D. King, MD @doctorORbust]

This is one of the last tweets I sent before I had the ambulance bring me to my own ICU for respiratory failure. I had two seizures, acute renal failure, and later critical illness myopathy with failure to extubate. I woke up after a 10-day coma.

It changed who I am.

[The White House 46 Archived @WhiteHouse46]

In celebration of Jewish American Heritage Month, Ben Platt and Micaela Diamond performed live at the White House. Take a listen:

[NEJM @NEJM]

Withholding of prophylactic platelet transfusion before CVC placement in pts with a platelet count of 10,000 to 50,000 per cubic millimeter did not meet the predefined margin for noninferiority &amp; resulted in more CVC-related bleeding events than prophylactic platelet transfusion.

[CIR/SEIU @cirseiu]

Thank you to the over 30 elected officials who are calling on @MountSinaiNYC to end this strike now by agreeing to pay parity &amp; support for the frontline resident physicians at Elmhurst Hospital.

@mountsinainyc @icahnmountsinai are you listening yet?

#NYCDocsStrike

[CHEST @accpchest]

Ultrasound Corner: A Stunning Giant Mass in Right Ventricle, A Challenge for Treatment

Read the full research in the May @journal_CHEST issue to find out the diagnosis: https://t.co/nAtlsWjQJu
#MedEd #MedTwitter

[CIR/SEIU @cirseiu]

We are the resident physicians of Elmhurst Hospital, employed by @MountSinaiNYC, and we are #QueensStrikeReady.

It's time to invest in us and it's time to invest in health care for Queens.
#NYCDocsStrike #ForOurHealth

[Miri Forbes @MiriForbes]

Ever wondered how many symptoms make up all of adult psychopathology described in the DSM-5? It’s 628!

How many do you think repeat across multiple diagnoses? If you answered 231 symptoms repeating a total of 1022 times (median 3 times per symptom, range 2-22), good job!

🧵

[Health Nerd @GidMK]

My new piece looks at the complex question of cannabis and schizophrenia, and why weed probably isn't causing 30% of cases in young men https://t.co/qbc52aSAHu

[CIR/SEIU @cirseiu]

In a landslide victory, the residents and fellows of @uofpenn voted 892-110 to become the first housestaff union in Pennsylvania. 💜💪

[Patrick Wieruszewski @pwierusz]

Hydroxocobalamin for hypotension

🫀used in septic shock, liver tx, drug-induced hypotension, postop vasoplegia
👎🏼evidence is largely anecdotal
💉dosing is arbitrary
🔵 pos. hemodynamics but similar to methylene blue

@hannahbrokmeier @MayoAnesthesia

https://t.co/bdlZYo8lkl

[Marina Levochkina, MPH 🦠🧠 @marinantherocks]

@AlexCMcPherson @MeiselLab @MackJBender @IDM_PittPubHlth Awesome!!!!

[IDWeek @IDWeekmtg]

The Covid-19 pandemic has reversed years of progress made in the fight to end tuberculosis. for this #WorldTBDay, IDWeek invites you to (re) watch this session on "Finding the “Missing” Millions With Tuberculosis. #EndTB

Watch on-demand: https://t.co/WIHNlvtvYO

[Marina Levochkina, MPH 🦠🧠 @marinantherocks]

@MedFitBlondie